Animalcare Group plc (AIM:ANCR)

Market Cap	156.04M +2.4%
Revenue (ttm)	81.07M +11.9%
Net Income	2.98M -83.8%
EPS	0.05 -85.1%
Shares Out	69.05M
PE Ratio	50.07
Forward PE	15.71
Dividend	0.05 (2.14%)
Ex-Dividend Date	Oct 16, 2025

Volume	78,219
Average Volume	103,322
Open	243.00
Previous Close	243.00
Day's Range	226.00 - 246.00
52-Week Range	202.00 - 305.35
Beta	0.34
RSI	21.51
Earnings Date	Mar 27, 2026

About Animalcare Group

Animalcare Group plc develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets. The company has a collaboration with 272Bio Limited to develop and commercialize a novel biological treatment for a common equine skin condition, known as sweet itch. The company operates in Belgium, the Netherlands, the United Kingdom, Germany, Spain, Italy, Portugal, Asia, the Middle East, Africa, European Union, and internationally. Animalcare Group plc is based in York, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Jennifer Ann Winter
• Employees: 201
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: ANCR

Financial Performance

In 2024, Animalcare Group's revenue was 74.23 million, an increase of 4.94% compared to the previous year's 70.73 million. Earnings were 18.49 million, an increase of 1442.45%.